Influence of polyvascular disease on cardiovascular event rates. Insights from the REACH registry

Vascular Medicine

Volumn 15, Issue 4, 2010, Pages 259-265

  Suárez, Carmen ^a   Zeymer, Uwe ^b   Limbourg, Tobias ^b   Baumgartner, Iris ^c   Cacoub, Patrice ^d   Poldermans, Don ^e   Röther, Joachim ^f   Bhatt, Deepak L ^g   Steg, Ph Gabriel ^h  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c BERN UNIVERSITY HOSPITAL   (Switzerland)

^d SORBONNE UNIVERSITÉ   (France)

^e ERASMUS MEDICAL CENTER   (Netherlands)

^f KLINIKUM MINDEN   (Germany)

^g BRIGHAM AND WOMEN S HOSPITAL   (United States)

^h INSERM   (France)

Author keywords

Atherothrombotic disease; Cerebrovascular disease; Coronary artery disease; Peripheral arterial disease; Polyvascular disease

Indexed keywords

CHOLESTEROL; GLUCOSE;

AGED; ARTERY DISEASE; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMOKING; VASCULAR DISEASE;

AGED; ATHEROSCLEROSIS; COMORBIDITY; CORONARY ARTERY DISEASE; EUROPE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; REGISTRIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; THROMBOSIS; VASCULAR DISEASES;

EID: 77955963457     PISSN: 1358863X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1358863X10373299     Document Type: Article

References (23)

1. Murray CJ, Lopez AD Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997 ; 349: 1498-1504.
2. Steg PG, Bhatt DL, Wilson PW, et al. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA 2007 ; 297: 1197-1206.
3. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): acollaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients with Peripheral Arterial Disease). Circulation 2006 ; 113: e463-654.
4. Coccheri S., on behalf of the CAPRIE Investigators. Distribution of symptomatic atherothrombosis and influence of atherosclerotic disease burden on risk of secondary ischaemic events: results from CAPRIE. Eur Heart J 1998 ; 19 (suppl): P1268.
5. Bhatt DL, Peterson ED, Harrington RA, et al. Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromes. Eur Heart J 2009 ; 30: 1195-1202.
6. Bhatt DL, Steg PG, Ohman EM, et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 2006 ; 295: 180-189.
7. Alberts MJ, Bhatt DL, Mas JL, et al. Three-year follow-up and event rates in the international reduction of atherothrombosis for continued health registry. Eur Heart J 2009 ; 30: 2318-2326.
8. Cacoub PP, Abola MT, Baumgartner I., et al. Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the reduction of atherothrombosis for continued health (REACH) registry. Atherosclerosis 2009 ; 204: e86-92.
9. Belch JJ, Topol EJ, Agnelli G., et al. Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med 2003 ; 163: 884-892.
10. Hirsch AT, Criqui MH, Treat-Jacobson D., et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001 ; 286: 1317-1324.
11. Resnick HE, Lindsay RS, McDermott MM, et al. Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: The Strong Heart Study. Circulation 2004 ; 109: 733-739.
12. Ohman EM, Bhatt DL, Steg PG, et al. The REduction of Atherothrombosis for Continued Health (REACH) Registry: an international, prospective, observational investigation in subjects at risk for atherothrombotic events-study design. Am Heart J 2006 ; 151: 786.e1-10.
13. Bhatt DL Diffuse coronary disease and atherothrombosis: a rationale for long-term therapy to prevent recurrent ischemic events. J Invasive Cardiol 2003 ; 15 suppl B: 3B - 9B ; discussion 9B - 10B.
14. Sleight P. The HOPE study (Heart Outcomes Prevention Evaluation). J Renin Angiotensin Aldosterone Syst 2000 ; 1: 18-20.
15. Brilakis ES, Hernandez AF, Dai D., et al. Quality of care for acute coronary syndrome patients with known atherosclerotic disease: results from the Get with the Guidelines Program. Circulation 2009 ; 120: 560-567.
16. Staat P., Cucherat M., George M., et al. Severe morbidity after coronary artery surgery: development and validation of a simple predictive clinical score. Eur Heart J 1999 ; 20: 960-966.
17. Birkmeyer JD, Quinton HB, O'Connor NJ, et al. The effect of peripheral vascular disease on long-term mortality after coronary artery bypass surgery. Northern New England Cardiovascular Disease Study Group. Arch Surg 1996 ; 131: 316-321.
18. Adams RJ, Chimowitz MI, Alpert JS, et al. Coronary risk evaluation in patients with transient ischemic attack and ischemic stroke: a scientific statement for healthcare professionals from the Stroke Council and the Council on Clinical Cardiology of the American Heart Association/American Stroke Association. Stroke 2003 ; 34: 2310-2322.
19. Sacco RL, Adams R., Albers G., et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council On Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Circulation 2006 ; 113: e409-449.
20. Wilterdink JL, Furie KL, Easton JD Cardiac evaluation of stroke patients. Neurology 1998 ; 51: S23-26.
21. Cacoub P., Cambou JP, Kownator S., et al. Prevalence of peripheral arterial disease in high-risk patients using ankle- brachial index in general practice: a cross-sectional study. Int J Clin Pract 2009 ; 63: 63-70.
22. Mourad JJ, Cacoub P., Collet JP, et al. Screening of unrecognized peripheral arterial disease (PAD) using ankle-brachial index in high cardiovascular risk patients free from symptomatic PAD. J Vasc Surg 2009 ; 50: 572-580.
23. Mostaza JM, Manzano L., Suarez C., et al. [Prevalence of asymptomatic peripheral artery disease detected by the ankle-brachial index in patients with cardiovascular disease. Merito II study.] Med Clin (Barc) 2008 ; 131: 561-565.